New York City, NY -- (SBWIRE) -- 01/16/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Lantronix Inc (NASDAQ:LTRX), China Finance Online Co. (ADR) (NASDAQ:JRJC), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Tengion, Inc. (OTCMKTS:TNGN)
Lantronix Inc (NASDAQ:LTRX) gained 19.13%, trading on 2.54 million shares, to end the trade at $2.74. The stock changed hands in a range of $2.11 to $3.03, bringing its market capitalization to about $39.95 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $1.31 and was moved to the maximum level of $3.03. Lantronix, Inc. designs, develops, markets and sells products that make it possible to access, manage, control and configure electronic products over the Internet or other networks. Its device management solutions address applications that manage equipment at data centers and remote branch offices to provide management for information technology (IT) systems.
Will LTRX Continue To Move Higher? Find Out Here
China Finance Online Co. (ADR) (NASDAQ:JRJC) added 18.68%, to complete the trading session at $7.18, with a total volume of 3.10 million shares. The stock, on average, trades on a volume of 575,546 shares. It floated in a range of $5.91 to $7.44 during the last trading session, with a beta value of 1.33. Its market capitalization now moved to about $59.30 million. In the past 52 weeks, the share price has not declined below $1.14 and above $7.44. China Finance Online Co. Limited (CFO Hong Kong) is a provider of vertically integrated financial services, including news, data, analytics and brokerage through Web portals, software systems and mobile handsets. The Company has two principal operating segments: online financial data subscription service and other related services, and brokerage service.
Why Should Investors Buy JRJC After The Recent Gain? Just Go Here and Find Out
Agios Pharmaceuticals Inc (NASDAQ:AGIO) recorded a gain of 18.58% and was in a range of $35.65-$44.04 before closing at $42.19. The stock completed the day with a total volume of 1.06 million shares, versus an average volume of 196,608 shares. The share price hit its 52-week low of $15.77 and $44.04 was the best price. Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is intend to apply its deep understanding of metabolism, coupled with the Company’s ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and inborn errors of metabolism (IEMs) are treated.
What was the Moving Force behind AGIO on Bullish Run? Read This Research Report
Tengion, Inc. (OTCMKTS:TNGN) added 17.39% yesterday, bringing its market capitalization around $1.19 million. The share price, after opening at $0.27, made a high of $0.29 and hovered above $0.24 to end the day at $0.270. The total number of shares that changed hands during the session was 1.36 million shares, as compared to average trading volume of 145,197 shares. Tengion, Inc. (Tengion) is a regenerative medicine company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues. The Company focuses on creating these functional neo-organs and neo-tissues using a patient’s own cells, or autologous cells, in conjunction with its Organ Regeneration Platform.
For How Long TNGN will fight for Profitability? Read This Trend Analysis report
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)